In vitro fertilizationProspective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies
Presented in part at the 60th Annual Meeting of the American Society for Reproductive Medicine (ASRM), Philadelphia, Pennsylvania, October 2004.
Under an Elsevier user license
open archive
Key Words
Antagonist
cetrorelix acetate
ganirelix acetate
oral contraceptives programming
assisted reproductive technology
inhibition of premature LH surge
follitropin alfa
Cited by (0)
Supported by Serono, Inc., Rockland, Massachusetts.
Copyright © 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.